Role of MT1 melatonin receptors in methamphetamine-induced locomotor sensitization in C57BL/6 mice

Rationale Melatonin modifies physiological and behavioral responses to psychostimulants, with the MT 1 and MT 2 melatonin receptors specifically implicated in facilitating methamphetamine (METH)-induced sensitization in melatonin-proficient mice. Objective The objective of the study is to assess dif...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychopharmacology 2014-01, Vol.231 (1), p.257-267
Hauptverfasser: Hutchinson, Anthony J., Ma, Jason, Liu, Jiabei, Hudson, Randall L., Dubocovich, Margarita L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 267
container_issue 1
container_start_page 257
container_title Psychopharmacology
container_volume 231
creator Hutchinson, Anthony J.
Ma, Jason
Liu, Jiabei
Hudson, Randall L.
Dubocovich, Margarita L.
description Rationale Melatonin modifies physiological and behavioral responses to psychostimulants, with the MT 1 and MT 2 melatonin receptors specifically implicated in facilitating methamphetamine (METH)-induced sensitization in melatonin-proficient mice. Objective The objective of the study is to assess differences in locomotor sensitization after a single dose of methamphetamine in low-melatonin-expressing C57BL/6 wild-type and MT 1 receptor knockout (MT 1 KO) mice, comparing with melatonin-expressing C3H/HeN mice. Methods Mice received a vehicle or methamphetamine (1.2 mg/kg, i.p.) pretreatment (day 1) during the light (ZT5-9) or dark (ZT 19–21) periods in novel test arenas. Locomotor sensitization was assessed by methamphetamine challenge after an eight-day abstinence (day 9). TH protein expression was evaluated by immunofluorescence and Western blot analysis. Results Methamphetamine pretreatment induced statistically significant locomotor sensitization upon challenge after eight-day abstinence in C3H and C57 wild-type mice during the light period. The magnitude of sensitization in C57 mice was diminished in the dark period and completely abrogated in MT 1 KO mice. No differences were observed in tyrosine hydroxylase immunoreactivity in the mesolimbic dopamine system. Additional exposures to the test arenas after methamphetamine pretreatment (nights 2–6) enhanced sensitization. Conclusions Deletion of the MT 1 melatonin receptor abolishes sensitization induced by a single METH pretreatment. The magnitude of sensitization is also altered by time of day and contextual cues. We conclude that the MT 1 melatonin receptor is emerging as a novel target of therapeutic intervention for drug abuse disorders.
doi_str_mv 10.1007/s00213-013-3228-0
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4696604</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>23934259</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-21bf9919ecea55ef96d46b9e245c110b68e6f22835f08070efd01588156787ab3</originalsourceid><addsrcrecordid>eNp9kN1KwzAUx4Mobk4fwBvpC9SdpE3a3gg6_IKJIPM6pO3pltEmJekEfXozqqI3BkII_4_D-RFyTuGSAmRzD8BoEkO4CWN5DAdkStOExQwydkimAElQKM8n5MT7LYST5ukxmbCkSFLGiykpX2yLkW2ipxWNOmzVYI02kcMK-8E6H4VPh8NGdf0GB9Vpg7E29a7COmptZTsbXJFH4_WgP9SgrdlHFjy7Wc5F1OkKT8lRo1qPZ1_vjLze3a4WD_Hy-f5xcb2MKw75EDNaNkVBizBZcY5NIepUlAWylFeUQilyFE3YMuEN5JABNjWE1XLKRZZnqkxm5Grs7Xdlh3WFZnCqlb3TnXLv0iot_ypGb-TavslUFEJAGgroWFA5673D5idLQe6ByxG4DMDlHriEkLn4PfQn8U04GNho8EEya3Rya3fOBBD_tH4CjxyMpw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Role of MT1 melatonin receptors in methamphetamine-induced locomotor sensitization in C57BL/6 mice</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Hutchinson, Anthony J. ; Ma, Jason ; Liu, Jiabei ; Hudson, Randall L. ; Dubocovich, Margarita L.</creator><creatorcontrib>Hutchinson, Anthony J. ; Ma, Jason ; Liu, Jiabei ; Hudson, Randall L. ; Dubocovich, Margarita L.</creatorcontrib><description>Rationale Melatonin modifies physiological and behavioral responses to psychostimulants, with the MT 1 and MT 2 melatonin receptors specifically implicated in facilitating methamphetamine (METH)-induced sensitization in melatonin-proficient mice. Objective The objective of the study is to assess differences in locomotor sensitization after a single dose of methamphetamine in low-melatonin-expressing C57BL/6 wild-type and MT 1 receptor knockout (MT 1 KO) mice, comparing with melatonin-expressing C3H/HeN mice. Methods Mice received a vehicle or methamphetamine (1.2 mg/kg, i.p.) pretreatment (day 1) during the light (ZT5-9) or dark (ZT 19–21) periods in novel test arenas. Locomotor sensitization was assessed by methamphetamine challenge after an eight-day abstinence (day 9). TH protein expression was evaluated by immunofluorescence and Western blot analysis. Results Methamphetamine pretreatment induced statistically significant locomotor sensitization upon challenge after eight-day abstinence in C3H and C57 wild-type mice during the light period. The magnitude of sensitization in C57 mice was diminished in the dark period and completely abrogated in MT 1 KO mice. No differences were observed in tyrosine hydroxylase immunoreactivity in the mesolimbic dopamine system. Additional exposures to the test arenas after methamphetamine pretreatment (nights 2–6) enhanced sensitization. Conclusions Deletion of the MT 1 melatonin receptor abolishes sensitization induced by a single METH pretreatment. The magnitude of sensitization is also altered by time of day and contextual cues. We conclude that the MT 1 melatonin receptor is emerging as a novel target of therapeutic intervention for drug abuse disorders.</description><identifier>ISSN: 0033-3158</identifier><identifier>EISSN: 1432-2072</identifier><identifier>DOI: 10.1007/s00213-013-3228-0</identifier><identifier>PMID: 23934259</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Animals ; Biomedical and Life Sciences ; Biomedicine ; Blotting, Western ; Brain - enzymology ; Central Nervous System Stimulants - pharmacology ; Circadian Rhythm - drug effects ; Darkness ; Light ; Male ; Melatonin - genetics ; Melatonin - metabolism ; Methamphetamine - pharmacology ; Mice ; Mice, Inbred C3H ; Mice, Inbred C57BL ; Mice, Knockout ; Motor Activity - drug effects ; Neurosciences ; Original Investigation ; Pharmacology/Toxicology ; Psychiatry ; Receptor, Melatonin, MT1 - drug effects ; Receptor, Melatonin, MT1 - genetics ; Species Specificity ; Tyrosine 3-Monooxygenase - metabolism</subject><ispartof>Psychopharmacology, 2014-01, Vol.231 (1), p.257-267</ispartof><rights>Springer-Verlag Berlin Heidelberg 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-21bf9919ecea55ef96d46b9e245c110b68e6f22835f08070efd01588156787ab3</citedby><cites>FETCH-LOGICAL-c508t-21bf9919ecea55ef96d46b9e245c110b68e6f22835f08070efd01588156787ab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00213-013-3228-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00213-013-3228-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23934259$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hutchinson, Anthony J.</creatorcontrib><creatorcontrib>Ma, Jason</creatorcontrib><creatorcontrib>Liu, Jiabei</creatorcontrib><creatorcontrib>Hudson, Randall L.</creatorcontrib><creatorcontrib>Dubocovich, Margarita L.</creatorcontrib><title>Role of MT1 melatonin receptors in methamphetamine-induced locomotor sensitization in C57BL/6 mice</title><title>Psychopharmacology</title><addtitle>Psychopharmacology</addtitle><addtitle>Psychopharmacology (Berl)</addtitle><description>Rationale Melatonin modifies physiological and behavioral responses to psychostimulants, with the MT 1 and MT 2 melatonin receptors specifically implicated in facilitating methamphetamine (METH)-induced sensitization in melatonin-proficient mice. Objective The objective of the study is to assess differences in locomotor sensitization after a single dose of methamphetamine in low-melatonin-expressing C57BL/6 wild-type and MT 1 receptor knockout (MT 1 KO) mice, comparing with melatonin-expressing C3H/HeN mice. Methods Mice received a vehicle or methamphetamine (1.2 mg/kg, i.p.) pretreatment (day 1) during the light (ZT5-9) or dark (ZT 19–21) periods in novel test arenas. Locomotor sensitization was assessed by methamphetamine challenge after an eight-day abstinence (day 9). TH protein expression was evaluated by immunofluorescence and Western blot analysis. Results Methamphetamine pretreatment induced statistically significant locomotor sensitization upon challenge after eight-day abstinence in C3H and C57 wild-type mice during the light period. The magnitude of sensitization in C57 mice was diminished in the dark period and completely abrogated in MT 1 KO mice. No differences were observed in tyrosine hydroxylase immunoreactivity in the mesolimbic dopamine system. Additional exposures to the test arenas after methamphetamine pretreatment (nights 2–6) enhanced sensitization. Conclusions Deletion of the MT 1 melatonin receptor abolishes sensitization induced by a single METH pretreatment. The magnitude of sensitization is also altered by time of day and contextual cues. We conclude that the MT 1 melatonin receptor is emerging as a novel target of therapeutic intervention for drug abuse disorders.</description><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Blotting, Western</subject><subject>Brain - enzymology</subject><subject>Central Nervous System Stimulants - pharmacology</subject><subject>Circadian Rhythm - drug effects</subject><subject>Darkness</subject><subject>Light</subject><subject>Male</subject><subject>Melatonin - genetics</subject><subject>Melatonin - metabolism</subject><subject>Methamphetamine - pharmacology</subject><subject>Mice</subject><subject>Mice, Inbred C3H</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Motor Activity - drug effects</subject><subject>Neurosciences</subject><subject>Original Investigation</subject><subject>Pharmacology/Toxicology</subject><subject>Psychiatry</subject><subject>Receptor, Melatonin, MT1 - drug effects</subject><subject>Receptor, Melatonin, MT1 - genetics</subject><subject>Species Specificity</subject><subject>Tyrosine 3-Monooxygenase - metabolism</subject><issn>0033-3158</issn><issn>1432-2072</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kN1KwzAUx4Mobk4fwBvpC9SdpE3a3gg6_IKJIPM6pO3pltEmJekEfXozqqI3BkII_4_D-RFyTuGSAmRzD8BoEkO4CWN5DAdkStOExQwydkimAElQKM8n5MT7LYST5ukxmbCkSFLGiykpX2yLkW2ipxWNOmzVYI02kcMK-8E6H4VPh8NGdf0GB9Vpg7E29a7COmptZTsbXJFH4_WgP9SgrdlHFjy7Wc5F1OkKT8lRo1qPZ1_vjLze3a4WD_Hy-f5xcb2MKw75EDNaNkVBizBZcY5NIepUlAWylFeUQilyFE3YMuEN5JABNjWE1XLKRZZnqkxm5Grs7Xdlh3WFZnCqlb3TnXLv0iot_ypGb-TavslUFEJAGgroWFA5673D5idLQe6ByxG4DMDlHriEkLn4PfQn8U04GNho8EEya3Rya3fOBBD_tH4CjxyMpw</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Hutchinson, Anthony J.</creator><creator>Ma, Jason</creator><creator>Liu, Jiabei</creator><creator>Hudson, Randall L.</creator><creator>Dubocovich, Margarita L.</creator><general>Springer Berlin Heidelberg</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20140101</creationdate><title>Role of MT1 melatonin receptors in methamphetamine-induced locomotor sensitization in C57BL/6 mice</title><author>Hutchinson, Anthony J. ; Ma, Jason ; Liu, Jiabei ; Hudson, Randall L. ; Dubocovich, Margarita L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-21bf9919ecea55ef96d46b9e245c110b68e6f22835f08070efd01588156787ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Blotting, Western</topic><topic>Brain - enzymology</topic><topic>Central Nervous System Stimulants - pharmacology</topic><topic>Circadian Rhythm - drug effects</topic><topic>Darkness</topic><topic>Light</topic><topic>Male</topic><topic>Melatonin - genetics</topic><topic>Melatonin - metabolism</topic><topic>Methamphetamine - pharmacology</topic><topic>Mice</topic><topic>Mice, Inbred C3H</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Motor Activity - drug effects</topic><topic>Neurosciences</topic><topic>Original Investigation</topic><topic>Pharmacology/Toxicology</topic><topic>Psychiatry</topic><topic>Receptor, Melatonin, MT1 - drug effects</topic><topic>Receptor, Melatonin, MT1 - genetics</topic><topic>Species Specificity</topic><topic>Tyrosine 3-Monooxygenase - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hutchinson, Anthony J.</creatorcontrib><creatorcontrib>Ma, Jason</creatorcontrib><creatorcontrib>Liu, Jiabei</creatorcontrib><creatorcontrib>Hudson, Randall L.</creatorcontrib><creatorcontrib>Dubocovich, Margarita L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hutchinson, Anthony J.</au><au>Ma, Jason</au><au>Liu, Jiabei</au><au>Hudson, Randall L.</au><au>Dubocovich, Margarita L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of MT1 melatonin receptors in methamphetamine-induced locomotor sensitization in C57BL/6 mice</atitle><jtitle>Psychopharmacology</jtitle><stitle>Psychopharmacology</stitle><addtitle>Psychopharmacology (Berl)</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>231</volume><issue>1</issue><spage>257</spage><epage>267</epage><pages>257-267</pages><issn>0033-3158</issn><eissn>1432-2072</eissn><abstract>Rationale Melatonin modifies physiological and behavioral responses to psychostimulants, with the MT 1 and MT 2 melatonin receptors specifically implicated in facilitating methamphetamine (METH)-induced sensitization in melatonin-proficient mice. Objective The objective of the study is to assess differences in locomotor sensitization after a single dose of methamphetamine in low-melatonin-expressing C57BL/6 wild-type and MT 1 receptor knockout (MT 1 KO) mice, comparing with melatonin-expressing C3H/HeN mice. Methods Mice received a vehicle or methamphetamine (1.2 mg/kg, i.p.) pretreatment (day 1) during the light (ZT5-9) or dark (ZT 19–21) periods in novel test arenas. Locomotor sensitization was assessed by methamphetamine challenge after an eight-day abstinence (day 9). TH protein expression was evaluated by immunofluorescence and Western blot analysis. Results Methamphetamine pretreatment induced statistically significant locomotor sensitization upon challenge after eight-day abstinence in C3H and C57 wild-type mice during the light period. The magnitude of sensitization in C57 mice was diminished in the dark period and completely abrogated in MT 1 KO mice. No differences were observed in tyrosine hydroxylase immunoreactivity in the mesolimbic dopamine system. Additional exposures to the test arenas after methamphetamine pretreatment (nights 2–6) enhanced sensitization. Conclusions Deletion of the MT 1 melatonin receptor abolishes sensitization induced by a single METH pretreatment. The magnitude of sensitization is also altered by time of day and contextual cues. We conclude that the MT 1 melatonin receptor is emerging as a novel target of therapeutic intervention for drug abuse disorders.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>23934259</pmid><doi>10.1007/s00213-013-3228-0</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0033-3158
ispartof Psychopharmacology, 2014-01, Vol.231 (1), p.257-267
issn 0033-3158
1432-2072
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4696604
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Animals
Biomedical and Life Sciences
Biomedicine
Blotting, Western
Brain - enzymology
Central Nervous System Stimulants - pharmacology
Circadian Rhythm - drug effects
Darkness
Light
Male
Melatonin - genetics
Melatonin - metabolism
Methamphetamine - pharmacology
Mice
Mice, Inbred C3H
Mice, Inbred C57BL
Mice, Knockout
Motor Activity - drug effects
Neurosciences
Original Investigation
Pharmacology/Toxicology
Psychiatry
Receptor, Melatonin, MT1 - drug effects
Receptor, Melatonin, MT1 - genetics
Species Specificity
Tyrosine 3-Monooxygenase - metabolism
title Role of MT1 melatonin receptors in methamphetamine-induced locomotor sensitization in C57BL/6 mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T12%3A43%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20MT1%20melatonin%20receptors%20in%20methamphetamine-induced%20locomotor%20sensitization%20in%20C57BL/6%20mice&rft.jtitle=Psychopharmacology&rft.au=Hutchinson,%20Anthony%20J.&rft.date=2014-01-01&rft.volume=231&rft.issue=1&rft.spage=257&rft.epage=267&rft.pages=257-267&rft.issn=0033-3158&rft.eissn=1432-2072&rft_id=info:doi/10.1007/s00213-013-3228-0&rft_dat=%3Cpubmed_cross%3E23934259%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/23934259&rfr_iscdi=true